Evaluation of a Smoking Cessation Patient Decision Aid that Integrates Information About E-cigarette
Saturday, June 19, 2021
Posted by: Natalia Gromov
Kollath-Cattano
C, Thrasher JF, Salloum RG, Albano AW, Jindal M, Durkin M, Strayer SM.
Evaluation of a Smoking
Cessation Patient Decision Aid that Integrates Information About E-cigarettes.
Nicotine Tob Res. 2021 May 13:ntab095. doi: 10.1093/ntr/ntab095. Epub ahead of
print. PMID: 33984145.
Introduction.
Smokers increasingly use e-cigarettes to try to quit smoking, even more than
recommended cessation methods. However, few smokers discuss the range of
cessation options with their physicians. Decision aids can inform smokers about
smoking cessation options, including evidence about e-cigarettes, and encourage
smokers to engage in shared decision making with their physician. This study
aimed to evaluate a smoking cessation decision aid that included e-cigarette
risks and benefits.
Methods.
Adult smokers were recruited from primary care clinics for two research phases:
1. usability and acceptability testing of the decision aid (n=37); and 2.
pre/post study that compared usual care (n=90) with implementation of the
decision aid in clinics (n=90). For the latter, outcome measures included
frequency of clinical discussions of readiness to quit, methods to quit in
general, and of specific cessation methods, in addition to decisional conflict,
communication satisfaction, and overall patient satisfaction.
Results.
Smokers indicated high usability and acceptability of the decision aid. In the
pre/post evaluation, decision aid implementation was associated with higher
rates of smokers: being asked if they were ready to quit smoking (89% vs. 67%,
respectively; p<0.001); discussing methods for smoking cessation in general
(81% vs. 48%; p<0.001); and discussing specific cessation methods (NRT 55%
vs. 26%, p<0.001; prescription medications 26% vs. 12%, p=0.022). Decision
aid use was also associated with higher overall patient satisfaction with the
physician visit.
Conclusions.
Smoking cessation decision aids that incorporate information about e-cigarettes
are acceptable among smokers and can lead to evidence-based clinical
discussions about smoking cessation.
Implications.
Smokers use e-cigarettes more than recommended cessation methods when they are
trying to quit smoking, yet few physicians discuss the risks and benefits of
e-cigarettes with their patients who smoke. This study presents preliminary
findings about the feasibility and usability of a clinically based
iPad-delivered smoking cessation decision aid that integrates information about
e-cigarettes. Although promising, further research with randomized designs,
larger samples, and longer-term follow-up is needed to determine whether this
type of intervention can effectively promote cessation of all tobacco products
and, for those not ready to quit smoking, the use of e-cigarettes for harm
reduction.
|
|
Email to a Friend